Bepotastine besilate nasal spray: Phase I/II started

Ista began a placebo-controlled Phase I/II trial to evaluate bepotastine nasal spray given twice daily in 96 patients in an environmental exposure chamber. Last year, FDA approved an NDA from Ista for...